speb/financial-data huggingface dataset:
DuPont ROE decomposition for CP8.AX (annual period ending 2023-12-31)
ROE: -37.09974545555505%
Net margin: -160.6359681003696%
Asset turnover: 0.20251175173375838
Equity multiplier (leverage): 1.1404543460897283
EBIT margin: -145.38295673548916%
ROE archetype: Low Return
DuPont ROE decomposition for CP8.AX (annual period ending 2024-12-31)
ROE: -14.992672005423453%
Net margin: -66.73351177408199%
Asset turnover: 0.19732875752968362
Equity multiplier (leverage): 1.138530525097261
EBIT margin: -62.14870730704841%
ROE archetype: Low Return
DuPont ROE decomposition for CP8.AX (annual period ending 2025-12-31)
ROE: -22.604913258858918%
Net margin: -95.81763753378868%
Asset turnover: 0.2165120593058167
Equity multiplier (leverage): 1.0896205751996486
EBIT margin: -70.38985699824202%
ROE archetype: Low Return
DuPont ROE decomposition for CPER.V (annual period ending 2022-12-31)
ROE: -55.15064574446219%
Asset turnover: 0
Equity multiplier (leverage): 1.0458733646663059
ROE archetype: Low Return
DuPont ROE decomposition for CPER.V (annual period ending 2023-12-31)
ROE: -39.99961634231944%
Asset turnover: 0
Equity multiplier (leverage): 1.048033969612907
ROE archetype: Low Return
DuPont ROE decomposition for CPER.V (annual period ending 2024-12-31)
ROE: -66.10163327727894%
Asset turnover: 0
Equity multiplier (leverage): 1.0688358524717112
ROE archetype: Low Return
DuPont ROE decomposition for CPER.V (annual period ending 2025-12-31)
ROE: -128.65627769143214%
Asset turnover: 0
Equity multiplier (leverage): 1.12606289285236
ROE archetype: Low Return
DuPont ROE decomposition for CPI.V (quarterly period ending 2025-01-31)
ROE: -1.2695681645998644%
Asset turnover: 0
Equity multiplier (leverage): 1.0424870409505962
ROE archetype: Low Return
DuPont ROE decomposition for CPI.V (quarterly period ending 2025-04-30)
ROE: -0.7497754335584369%
Asset turnover: 0
Equity multiplier (leverage): 1.0454979119740955
ROE archetype: Low Return
DuPont ROE decomposition for CPI.V (quarterly period ending 2025-07-31)
ROE: -4.716864802965156%
Asset turnover: 0
Equity multiplier (leverage): 1.036141179320556
ROE archetype: Low Return
DuPont ROE decomposition for CPI.V (quarterly period ending 2025-10-31)
ROE: -1.4585473057597735%
Asset turnover: 0
Equity multiplier (leverage): 1.0189357331966886
ROE archetype: Low Return
DuPont ROE decomposition for CPI.V (quarterly period ending 2026-01-31)
ROE: -1.7824232204697539%
Asset turnover: 0
Equity multiplier (leverage): 1.0132779112725827
ROE archetype: Low Return
DuPont ROE decomposition for CPI.V (quarterly period ending 2026-04-30)
ROE: -1.6603510336353284%
Asset turnover: 0
Equity multiplier (leverage): 1.015895045287698
ROE archetype: Low Return
DuPont ROE decomposition for CPO.AX (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0146971885860736
ROE archetype: Standard Business
DuPont ROE decomposition for CPP.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 121.44329128083965
ROE archetype: Standard Business
DuPont ROE decomposition for CPP.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 9.843364330159158
ROE archetype: Standard Business
DuPont ROE decomposition for CPSS (annual period ending 2022-12-31)
ROE: 37.64760999873024%
Net margin: 35.503024547350165%
Asset turnover: 0.0879787181484237
Equity multiplier (leverage): 12.052979784490496
Tax burden factor: 0.7400015491466784
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPSS (annual period ending 2023-12-31)
ROE: 18.02698302578038%
Net margin: 22.07728974647366%
Asset turnover: 0.07261822387428017
Equity multiplier (leverage): 11.244280469211242
Tax burden factor: 0.742147732294548
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CPSS (annual period ending 2024-12-31)
ROE: 6.768316538546943%
Net margin: 9.49473174156609%
Asset turnover: 0.06322638408631719
Equity multiplier (leverage): 11.274560392501032
Tax burden factor: 0.7000473916371988
ROE archetype: Standard Business
DuPont ROE decomposition for CPSS (annual period ending 2025-12-31)
ROE: 6.417003981364953%
Net margin: 9.545755411319561%
Asset turnover: 0.05507190432723559
Equity multiplier (leverage): 12.206521269919277
Tax burden factor: 0.6901046316466093
ROE archetype: Standard Business
DuPont ROE decomposition for CPZ (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 2.107518716754245
ROE archetype: Standard Business
DuPont ROE decomposition for CPZ (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 1.928916752591353
ROE archetype: Standard Business
DuPont ROE decomposition for CPZ (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 1.5624615730322697
ROE archetype: Standard Business
DuPont ROE decomposition for CRAN (annual period ending 2025-12-31)
Equity multiplier (leverage): 1.0445245444985995
ROE archetype: Standard Business
DuPont ROE decomposition for CRD.AX (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0529226091146815
ROE archetype: Standard Business
DuPont ROE decomposition for CRD.AX (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.1490822464829362
ROE archetype: Standard Business
DuPont ROE decomposition for CREO.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.5330188679245282
ROE archetype: Standard Business
DuPont ROE decomposition for CREO.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.2863992368711719
ROE archetype: Standard Business
DuPont ROE decomposition for CREO.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.1531152686168258
ROE archetype: Standard Business
DuPont ROE decomposition for CRN.AX (annual period ending 2022-12-31)
ROE: 69.95829896019363%
Net margin: 21.875986853481635%
Asset turnover: 1.383422348953519
Equity multiplier (leverage): 2.311621898485164
EBIT margin: 29.26412834013583%
Interest burden factor: 0.9718578088961949
Tax burden factor: 0.7691823893102304
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CRN.AX (annual period ending 2023-12-31)
ROE: 14.238238209903095%
Net margin: 5.513322021599689%
Asset turnover: 1.0855091463353885
Equity multiplier (leverage): 2.3790819825945433
EBIT margin: 16.427767232641948%
Interest burden factor: 0.26625578739793426
Tax burden factor: 1.2604794288206502
ROE archetype: Standard Business
DuPont ROE decomposition for CRN.AX (annual period ending 2024-12-31)
ROE: -9.507917023914754%
Net margin: -4.453461994991946%
Asset turnover: 0.8898355110642435
Equity multiplier (leverage): 2.399263234828569
EBIT margin: 6.1854206904111555%
Interest burden factor: -0.9865432302859977
ROE archetype: Low Return
DuPont ROE decomposition for CRN.AX (annual period ending 2025-12-31)
ROE: -52.604292849160004%
Net margin: -22.498042090880308%
Asset turnover: 0.7750412537282587
Equity multiplier (leverage): 3.0168355856007025
EBIT margin: -10.522095212703913%
ROE archetype: Low Return
DuPont ROE decomposition for CRN.L (annual period ending 2022-12-31)
ROE: 10.777817089683465%
Net margin: 13.125306751199064%
Asset turnover: 0.602142661375037
Equity multiplier (leverage): 1.3637097610870659
EBIT margin: 16.68920899900706%
Interest burden factor: 0.9072132929575276
Tax burden factor: 0.8668906196508046
ROE archetype: Standard Business
DuPont ROE decomposition for CRN.L (annual period ending 2023-12-31)
ROE: 11.568380142014957%
Net margin: 12.812103052307492%
Asset turnover: 0.6597024606757556
Equity multiplier (leverage): 1.36868662757897
EBIT margin: 17.004770495810632%
Interest burden factor: 0.8768310859078041
Tax burden factor: 0.8592780342576668
ROE archetype: Standard Business
DuPont ROE decomposition for CRN.L (annual period ending 2024-12-31)
ROE: 14.633864720412104%
Net margin: 13.324324230029855%
Asset turnover: 0.788326554897992
Equity multiplier (leverage): 1.393181464418501
EBIT margin: 17.445291212286495%
Interest burden factor: 0.8991047084469391
Tax burden factor: 0.8494869209324396
ROE archetype: Standard Business
DuPont ROE decomposition for CRN.L (annual period ending 2025-12-31)
ROE: 17.60148223008253%
Net margin: 14.049773132925262%
Asset turnover: 0.8375647108391309
Equity multiplier (leverage): 1.4957587739395766
EBIT margin: 17.847229426872154%
Interest burden factor: 0.9041379473977673
Tax burden factor: 0.8706905035263244
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CROMPTON.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.6057750640363098
ROE archetype: Standard Business
DuPont ROE decomposition for CROMPTON.NS (quarterly period ending 2024-12-31)
Net margin: 6.3254510105348825%
EBIT margin: 8.620631188678392%
Interest burden factor: 0.9912148429817086
Tax burden factor: 0.7402605992459818
ROE archetype: Standard Business
DuPont ROE decomposition for CROMPTON.NS (quarterly period ending 2025-03-31)
ROE: 4.463387694106946%
Net margin: 8.333575955202297%
Asset turnover: 0.32473598124214087
Equity multiplier (leverage): 1.6493119355467483
EBIT margin: 11.05773429993886%
Interest burden factor: 1.0128137616289274
Tax burden factor: 0.744107452339688
ROE archetype: Low Return
DuPont ROE decomposition for CROMPTON.NS (quarterly period ending 2025-06-30)
Net margin: 6.200146121280663%
EBIT margin: 7.616321546883914%
Interest burden factor: 1.0912614980289093
Tax burden factor: 0.745981094587272
ROE archetype: Standard Business
DuPont ROE decomposition for CROMPTON.NS (quarterly period ending 2025-12-31)
Net margin: 5.320549965758837%
EBIT margin: 7.990307116894063%
Interest burden factor: 0.896756329113924
Tax burden factor: 0.7425378620791061
ROE archetype: Standard Business
DuPont ROE decomposition for CROMPTON.NS (quarterly period ending 2026-03-31)
ROE: -15.457583113579343%
Net margin: -23.259185291270853%
Asset turnover: 0.3753803914476659
Equity multiplier (leverage): 1.7704167467095113
EBIT margin: 9.899836637804551%
Interest burden factor: -2.139444346133428
ROE archetype: Low Return
DuPont ROE decomposition for CROS.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.2106779174833868
ROE archetype: Standard Business
DuPont ROE decomposition for CROS.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.20214858035154
ROE archetype: Standard Business
DuPont ROE decomposition for CRPR.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.374064837905237
ROE archetype: Standard Business
DuPont ROE decomposition for CRPR.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 3.5515962478594703
ROE archetype: Standard Business
DuPont ROE decomposition for CRPR.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 3.3963114886412673
ROE archetype: Standard Business
DuPont ROE decomposition for CRR.AX (annual period ending 2021-12-31)
Equity multiplier (leverage): 3.1384265392487207
ROE archetype: Standard Business
DuPont ROE decomposition for CRR.AX (annual period ending 2022-12-31)
ROE: -16.474735820538484%
Equity multiplier (leverage): 1.4205734475230782
ROE archetype: Low Return
DuPont ROE decomposition for CRR.AX (annual period ending 2023-12-31)
ROE: -17.587508710250784%
Equity multiplier (leverage): 1.262618212056978
ROE archetype: Low Return
DuPont ROE decomposition for CRR.AX (annual period ending 2025-12-31)
ROE: -6.818788757180674%
Equity multiplier (leverage): 1.2577275584408312
ROE archetype: Low Return
DuPont ROE decomposition for CRVO (quarterly period ending 2025-03-31)
ROE: -14.130522562669977%
Asset turnover: 0
Equity multiplier (leverage): 1.113846092191289
ROE archetype: Low Return
DuPont ROE decomposition for CRVO (quarterly period ending 2025-06-30)
ROE: -18.38698929195946%
Asset turnover: 0
Equity multiplier (leverage): 1.12610669940973
ROE archetype: Low Return
DuPont ROE decomposition for CRVO (quarterly period ending 2025-09-30)
ROE: -25.993195802483054%
Asset turnover: 0
Equity multiplier (leverage): 1.155437187410867
ROE archetype: Low Return
DuPont ROE decomposition for CRVO (quarterly period ending 2025-12-31)
ROE: -36.56564302437709%
Asset turnover: 0
Equity multiplier (leverage): 1.2092362126143328
ROE archetype: Low Return
DuPont ROE decomposition for CRVO (quarterly period ending 2026-03-31)
ROE: -55.232595073217105%
Asset turnover: 0
Equity multiplier (leverage): 1.3173980332481974
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.TO (quarterly period ending 2024-12-31)
ROE: -127.50729713952127%
Net margin: -63.61624046135027%
Asset turnover: 0.11677119185927871
Equity multiplier (leverage): 17.164506713368354
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.TO (quarterly period ending 2025-03-31)
ROE: -23.22964495893423%
Net margin: -9.131120036605827%
Asset turnover: 0.13446636289989025
Equity multiplier (leverage): 18.91929121127854
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.TO (quarterly period ending 2025-06-30)
ROE: -67.25650328678721%
Net margin: -22.73639246650702%
Asset turnover: 0.10954402150391403
Equity multiplier (leverage): 27.00374800851484
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.TO (quarterly period ending 2025-09-30)
ROE: -7.99344298733051%
Net margin: -1.3856812933025404%
Asset turnover: 0.14413343666751866
Equity multiplier (leverage): 40.02264491315526
Tax burden factor: -1.3674418604651164
ROE archetype: Low Return
DuPont ROE decomposition for CRWN.TO (quarterly period ending 2025-12-31)
ROE: 40.0130649723413%
Net margin: 5.2359680311179995%
Asset turnover: 0.21788699338539655
Equity multiplier (leverage): 35.073049401300096
Tax burden factor: 0.5008720930232559
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CS.TO (annual period ending 2022-12-31)
ROE: 4.281294498870389%
Net margin: 9.892967105315748%
Asset turnover: 0.2557410385013087
Equity multiplier (leverage): 1.692186061255604
EBIT margin: 9.718636251661376%
Interest burden factor: 1.4484896066995663
Tax burden factor: 0.7027580902431848
ROE archetype: Low Return
DuPont ROE decomposition for CS.TO (annual period ending 2023-12-31)
ROE: -3.3050883254615484%
Net margin: -7.1477531806418995%
Asset turnover: 0.256373663876583
Equity multiplier (leverage): 1.803599526608699
EBIT margin: 1.2686713539407481%
Interest burden factor: -5.042834977280283
ROE archetype: Low Return
DuPont ROE decomposition for CS.TO (annual period ending 2024-12-31)
ROE: 2.531498484485615%
Net margin: 5.095844531464648%
Asset turnover: 0.2647892453486657
Equity multiplier (leverage): 1.87612236293336
EBIT margin: 8.797117454130932%
Interest burden factor: 0.8999440123577543
Tax burden factor: 0.6436655823226948
ROE archetype: Low Return
DuPont ROE decomposition for CS.TO (annual period ending 2025-12-31)
ROE: 9.783805071207494%
Net margin: 14.72762807315133%
Asset turnover: 0.3572270379928195
Equity multiplier (leverage): 1.8596476289457653
EBIT margin: 20.308350027098854%
Interest burden factor: 1.0064966303784344
Tax burden factor: 0.7205196720939959
ROE archetype: Standard Business
DuPont ROE decomposition for CSAN3.SA (annual period ending 2022-12-31)
ROE: 5.856155689216715%
Net margin: 5.9770347529861345%
Asset turnover: 0.3509330245563757
Equity multiplier (leverage): 2.791917582363857
EBIT margin: 12.618594359916708%
Interest burden factor: 0.4454170300639389
Tax burden factor: 1.0634277366759342
ROE archetype: Standard Business
DuPont ROE decomposition for CSAN3.SA (annual period ending 2023-12-31)
ROE: 10.259083004154036%
Net margin: 10.43917596156421%
Asset turnover: 0.3552982892684436
Equity multiplier (leverage): 2.765981105788705
EBIT margin: 16.212759547062625%
Interest burden factor: 0.6740731767502238
Tax burden factor: 0.9552174128149767
ROE archetype: Standard Business
DuPont ROE decomposition for CSAN3.SA (annual period ending 2024-12-31)
ROE: -15.6415677692028%
Net margin: -15.773410338848928%
Asset turnover: 0.3239190853390296
Equity multiplier (leverage): 3.0613863522051386
EBIT margin: 19.568572296915193%
Interest burden factor: -0.5180094312118835
ROE archetype: Low Return
DuPont ROE decomposition for CSAN3.SA (annual period ending 2025-12-31)
ROE: -29.485378923385987%
Net margin: -20.408555898907867%
Asset turnover: 0.3659040772510752
Equity multiplier (leverage): 3.9484549676966445
EBIT margin: 22.486347729108182%
Interest burden factor: -0.746017082070995
ROE archetype: Low Return
DuPont ROE decomposition for CSCO.TO (annual period ending 2022-07-31)
ROE: 29.698539210016843%
Net margin: 22.91056500572182%
Asset turnover: 0.5484670538924704
Equity multiplier (leverage): 2.363462650541825
EBIT margin: 27.105921601334444%
Interest burden factor: 1.0359212880143114
Tax burden factor: 0.8159148994957519
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSCO.TO (annual period ending 2023-07-31)
ROE: 29.44223635412186%
Net margin: 22.12884662619741%
Asset turnover: 0.5713341959508557
Equity multiplier (leverage): 2.3287442601632002
EBIT margin: 27.302712375872833%
Interest burden factor: 0.9843207813905668
Tax burden factor: 0.8234103668886278
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSCO.TO (annual period ending 2024-07-31)
ROE: 22.562948490917066%
Net margin: 19.181086556511715%
Asset turnover: 0.4676609970327594
Equity multiplier (leverage): 2.51530987355027
EBIT margin: 24.106462464918312%
Interest burden factor: 0.9432536622976098
Tax burden factor: 0.8435507601765572
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSCO.TO (annual period ending 2025-07-31)
ROE: 22.058504875406285%
Net margin: 17.968722420305717%
Asset turnover: 0.45928724301186846
Equity multiplier (leverage): 2.67284940411701
EBIT margin: 22.070815829420695%
Interest burden factor: 0.8877159309021113
Tax burden factor: 0.9171171171171171
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSG.AS (annual period ending 2021-12-31)
ROE: 14.232030087361386%
Net margin: 9.11633226554825%
Asset turnover: 0.5270885981903458
Equity multiplier (leverage): 2.9618501734225497
EBIT margin: 10.719152215105963%
Interest burden factor: 1.0700278176243736
Tax burden factor: 0.7948124097993448
ROE archetype: Standard Business
DuPont ROE decomposition for CSG.AS (annual period ending 2022-12-31)
ROE: 27.344109356382067%
Net margin: 13.932892326559138%
Asset turnover: 0.562964720591015
Equity multiplier (leverage): 3.486111886522604
EBIT margin: 16.971795374482486%
Interest burden factor: 1.0565059631082747
Tax burden factor: 0.777036717916783
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSG.AS (annual period ending 2023-12-31)
ROE: 2.591659929879318%
Net margin: 12.119889531431076%
Asset turnover: 0.05553501237349795
Equity multiplier (leverage): 3.850458790319756
EBIT margin: 21.444047900462976%
Interest burden factor: 0.7499435380660981
Tax burden factor: 0.753638931910744
ROE archetype: Low Return
DuPont ROE decomposition for CSG.AS (annual period ending 2024-12-31)
ROE: 58.66381617069196%
Net margin: 12.669804976462675%
Asset turnover: 0.8886666613476178
Equity multiplier (leverage): 5.210285164918591
EBIT margin: 22.98886861648394%
Interest burden factor: 0.7524703524134412
Tax burden factor: 0.7324246267732661
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CSH.DE (annual period ending 2022-12-31)
ROE: 14.757832213116586%
Net margin: 4.075805417139474%
Asset turnover: 1.2764155324826625
Equity multiplier (leverage): 2.8367237567827077
EBIT margin: 3.9758991563471313%
Interest burden factor: 1.4276407631456491
Tax burden factor: 0.7180573663624512
ROE archetype: Standard Business
DuPont ROE decomposition for CSH.DE (annual period ending 2023-12-31)
ROE: 11.354075270629114%
Net margin: 2.7008445214378516%
Asset turnover: 1.3422166772181496
Equity multiplier (leverage): 3.132056258316434
EBIT margin: 4.040710264183629%
Interest burden factor: 0.9117095391211147
Tax burden factor: 0.7331373989713446
ROE archetype: Standard Business
DuPont ROE decomposition for CSH.DE (annual period ending 2024-12-31)
ROE: -3.2900182522668646%
Net margin: -0.7572359441092349%
Asset turnover: 1.2945852117337062
Equity multiplier (leverage): 3.3561119947359703
EBIT margin: 3.4702628139273535%
Interest burden factor: -0.09631688672689367
ROE archetype: Low Return
DuPont ROE decomposition for CSH.DE (annual period ending 2025-12-31)
ROE: -2.8573617837946803%
Net margin: -0.5775380650088302%
Asset turnover: 1.4924798544871916
Equity multiplier (leverage): 3.3149435765751925
EBIT margin: 0.6233592668607705%
Interest burden factor: -1.5842266462480856
ROE archetype: Low Return
DuPont ROE decomposition for CSPN.V (quarterly period ending 2024-09-30)
Net margin: -124.580862093121%
Asset turnover: 0.37986517651232926
EBIT margin: -86.400006226747%
ROE archetype: Standard Business
DuPont ROE decomposition for CSPN.V (quarterly period ending 2024-12-31)
Asset turnover: -2.8289643078633904
ROE archetype: Standard Business
DuPont ROE decomposition for CSPN.V (quarterly period ending 2025-03-31)
Net margin: -100.23123274255634%
Asset turnover: 1.1944549372260875
EBIT margin: -61.48002557162094%
ROE archetype: Standard Business
DuPont ROE decomposition for CSW (annual period ending 2022-03-31)
ROE: 13.89708326194079%
Net margin: 10.746366342876755%
Asset turnover: 0.6293552081658897
Equity multiplier (leverage): 2.0547840573397385
EBIT margin: 15.545108431042326%
Interest burden factor: 0.9392585746559868
Tax burden factor: 0.7360083091893074
ROE archetype: Standard Business
DuPont ROE decomposition for CSW (annual period ending 2023-03-31)
ROE: 18.778669000048613%
Net margin: 12.742247039202853%
Asset turnover: 0.7434757380887801
Equity multiplier (leverage): 1.9822206018180935
EBIT margin: 18.348761848466296%
Interest burden factor: 0.905404628018351
Tax burden factor: 0.7670020887769933
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSW (annual period ending 2024-03-31)
ROE: 17.39103150649965%
Net margin: 12.933126482014027%
Asset turnover: 0.7598696364109472
Equity multiplier (leverage): 1.7696310348307394
EBIT margin: 20.259573179960647%
Interest burden factor: 0.8745782127426444
Tax burden factor: 0.7299188496583143
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CSW (annual period ending 2025-03-31)
ROE: 15.91700429114489%
Net margin: 15.653403559827439%
Asset turnover: 0.7251521327481815
Equity multiplier (leverage): 1.4022434589417954
EBIT margin: 20.636205583279533%
Interest burden factor: 0.9937599311440678
Tax burden factor: 0.7633038524958777
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CSW (annual period ending 2026-03-31)
ROE: 10.439946508307079%
Net margin: 10.42419326977347%
Asset turnover: 0.585834698189731
Equity multiplier (leverage): 1.709545750801057
EBIT margin: 17.011885836114576%
Interest burden factor: 0.7903530587200399
Tax burden factor: 0.7752983449327736
ROE archetype: Standard Business
DuPont ROE decomposition for CSWC (annual period ending 2023-03-31)
ROE: 5.605106976870232%
Net margin: 53.850910451890066%
Asset turnover: 0.04886203529662459
Equity multiplier (leverage): 2.1301947128087697
Tax burden factor: 0.8259621624319872
ROE archetype: Standard Business
DuPont ROE decomposition for CSWC (annual period ending 2024-03-31)
ROE: 12.389865714175341%
Net margin: 76.460879691182%
Asset turnover: 0.07750097532654786
Equity multiplier (leverage): 2.0908368274193885
Tax burden factor: 0.9856622774875299
ROE archetype: Standard Business
DuPont ROE decomposition for CSWC (annual period ending 2025-03-31)
ROE: 8.607041137454868%
Net margin: 64.81034055101834%
Asset turnover: 0.06329402447611611
Equity multiplier (leverage): 2.098199912280113
Tax burden factor: 0.8883684031581731
ROE archetype: Standard Business
DuPont ROE decomposition for CSWC (annual period ending 2026-03-31)
ROE: 11.927954080622815%
Net margin: 74.66301044006872%
Asset turnover: 0.07454515094481817
Equity multiplier (leverage): 2.1430932242528207
Tax burden factor: 0.9394173691824214
ROE archetype: Standard Business
DuPont ROE decomposition for CTA.L (annual period ending 2021-12-31)
ROE: -40.62293638564826%
Net margin: -8.665404119451575%
Asset turnover: 1.17738547156599
Equity multiplier (leverage): 3.9816567613177787
EBIT margin: -5.782414073749451%
ROE archetype: Low Return
DuPont ROE decomposition for CTA.L (annual period ending 2022-12-31)
ROE: -148.80168536944097%
Net margin: -19.847266816341964%
Asset turnover: 1.2373210299632273
Equity multiplier (leverage): 6.05933198321153
EBIT margin: -13.546419461007972%
ROE archetype: Low Return
DuPont ROE decomposition for CTA.L (annual period ending 2023-12-31)
ROE: 82.90770527820972%
Net margin: 4.416886986445088%
Asset turnover: 1.8546227991298925
Equity multiplier (leverage): 10.120990409725993
EBIT margin: 5.925552897729657%
Interest burden factor: 0.7007790368271954
Tax burden factor: 1.0636685194542699
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTA.L (annual period ending 2024-12-31)
ROE: 45.765980436486466%
Net margin: 6.521194508467783%
Asset turnover: 1.6006713955950662
Equity multiplier (leverage): 4.384432944835136
EBIT margin: 7.165881684871564%
Interest burden factor: 0.7731033679058384
Tax burden factor: 1.1771178776002411
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTA.L (annual period ending 2025-12-31)
ROE: 34.147040780608%
Net margin: 7.337612010484791%
Asset turnover: 1.6057232898429261
Equity multiplier (leverage): 2.898195132749863
EBIT margin: 9.411928626788466%
Interest burden factor: 0.846780162842339
Tax burden factor: 0.9206730769230769
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTAS (annual period ending 2022-05-31)
ROE: 37.35440705447924%
Net margin: 15.733190535465269%
Asset turnover: 0.9640618878307003
Equity multiplier (leverage): 2.4627488818679426
EBIT margin: 20.209794207341332%
Interest burden factor: 0.94418314570642
Tax burden factor: 0.8245152018190941
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CTAS (annual period ending 2023-05-31)
ROE: 37.589955190763426%
Net margin: 15.290895212885003%
Asset turnover: 1.0561847250313474
Equity multiplier (leverage): 2.3275499701485547
EBIT margin: 20.448176443824696%
Interest burden factor: 0.9392476911948094
Tax burden factor: 0.796156035975591
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CTAS (annual period ending 2024-05-31)
ROE: 38.42355065634047%
Net margin: 16.3765244307498%
Asset turnover: 1.0834345224853295
Equity multiplier (leverage): 2.165574293936769
EBIT margin: 21.55586110310771%
Interest burden factor: 0.9540769193955622
Tax burden factor: 0.7962931342421471
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CTAS (annual period ending 2025-05-31)
ROE: 40.26909449582167%
Net margin: 17.526588751202713%
Asset turnover: 1.088780607071959
Equity multiplier (leverage): 2.1102508839995497
EBIT margin: 22.820935146106244%
Interest burden factor: 0.9595190289042033
Tax burden factor: 0.8004060591766989
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CTG.V (annual period ending 2022-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTG.V (annual period ending 2023-12-31)
ROE: -376.90467318778144%
Asset turnover: 0
Equity multiplier (leverage): 1.3595421267520338
ROE archetype: Low Return
DuPont ROE decomposition for CTG.V (annual period ending 2024-12-31)
ROE: -228.88638708268948%
Asset turnover: 0
Equity multiplier (leverage): 1.1306305265065417
ROE archetype: Low Return
DuPont ROE decomposition for CTG.V (annual period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTGO (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CTGO (quarterly period ending 2025-06-30)
Asset turnover: 0
Tax burden factor: 1.0033045383014834
ROE archetype: Standard Business
DuPont ROE decomposition for CTGO (quarterly period ending 2025-09-30)
ROE: -23.747982029566238%
Asset turnover: 0
Equity multiplier (leverage): 8.164064557615921
ROE archetype: Low Return
DuPont ROE decomposition for CTGO (quarterly period ending 2025-12-31)
ROE: -66.0292289069003%
Asset turnover: 0
Equity multiplier (leverage): 5.343875274620732
ROE archetype: Low Return
DuPont ROE decomposition for CTGO (quarterly period ending 2026-03-31)
ROE: -8.254186803243812%
Asset turnover: 0
Equity multiplier (leverage): 1.9277178476535097
ROE archetype: Low Return
DuPont ROE decomposition for CTL.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.3568785247161035
ROE archetype: Standard Business
DuPont ROE decomposition for CTL.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.340925463443613
ROE archetype: Standard Business
DuPont ROE decomposition for CTM.V (quarterly period ending 2024-12-31)
ROE: -8.190171642173889%
Asset turnover: 0
Equity multiplier (leverage): 1.0506767285589398
ROE archetype: Low Return
DuPont ROE decomposition for CTM.V (quarterly period ending 2025-03-31)
ROE: -4.014683888400576%
Asset turnover: 0
Equity multiplier (leverage): 1.0538357279401673
ROE archetype: Low Return
DuPont ROE decomposition for CTM.V (quarterly period ending 2025-06-30)
ROE: -6.495391010767699%
Asset turnover: 0
Equity multiplier (leverage): 1.0664032357585118
ROE archetype: Low Return
DuPont ROE decomposition for CTM.V (quarterly period ending 2025-09-30)
ROE: -6.510016367513997%
Asset turnover: 0
Equity multiplier (leverage): 1.0785225133853382
ROE archetype: Low Return
DuPont ROE decomposition for CTM.V (quarterly period ending 2025-12-31)
ROE: -9.83611885579467%
Asset turnover: 0
Equity multiplier (leverage): 1.0685730971664866
ROE archetype: Low Return
DuPont ROE decomposition for CTMX (quarterly period ending 2025-03-31)
ROE: 93.91592478741666%
Net margin: 46.202643517882045%
Asset turnover: 0.5169396022213875
Equity multiplier (leverage): 3.9321729410355704
EBIT margin: 44.42720505921402%
Interest burden factor: 1.0427036824189913
Tax burden factor: 0.9973714334167126
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CTMX (quarterly period ending 2025-06-30)
ROE: -0.21247387192240563%
Net margin: -0.825383213634902%
Asset turnover: 0.13641182362531712
Equity multiplier (leverage): 1.8871129077877193
EBIT margin: -6.8924857969771685%
ROE archetype: Low Return
DuPont ROE decomposition for CTMX (quarterly period ending 2025-09-30)
ROE: -12.520072679598238%
Net margin: -238.62149924534629%
Asset turnover: 0.03578039728661821
Equity multiplier (leverage): 1.4663988842889761
EBIT margin: -264.43065571021293%
ROE archetype: Low Return
DuPont ROE decomposition for CTMX (quarterly period ending 2025-12-31)
ROE: -25.688357873418706%
Net margin: -3998.4917043740575%
Asset turnover: 0.004279904460654574
Equity multiplier (leverage): 1.5010877096081823
EBIT margin: -4212.971342383107%
ROE archetype: Low Return
DuPont ROE decomposition for CTMX (quarterly period ending 2026-03-31)
ROE: -8.711260478527374%
Net margin: -177.89042698381752%
Asset turnover: 0.04015470011195403
Equity multiplier (leverage): 1.2195287288281236
EBIT margin: -191.77227529732892%
ROE archetype: Low Return
DuPont ROE decomposition for CTRI (annual period ending 2022-12-31)
ROE: -30.347554975122094%
Net margin: -5.977045473235599%
Asset turnover: 1.124893636790423
Equity multiplier (leverage): 4.513627208431818
EBIT margin: 2.740834690962339%
Interest burden factor: -2.163582531458179
ROE archetype: Low Return
DuPont ROE decomposition for CTRI (annual period ending 2023-12-31)
ROE: -42.46847767542709%
Net margin: -6.363864633791333%
Asset turnover: 1.2486749972651496
Equity multiplier (leverage): 5.3443678732385935
EBIT margin: 4.705588567628608%
Interest burden factor: -1.2825519688040579
ROE archetype: Low Return
DuPont ROE decomposition for CTRI (annual period ending 2024-12-31)
ROE: -1.518734598644342%
Net margin: -0.25496458593470644%
Asset turnover: 1.2368877597203574
Equity multiplier (leverage): 4.8158364898348225
EBIT margin: 3.2906888252783513%
Interest burden factor: -0.03867116831637533
ROE archetype: Low Return
DuPont ROE decomposition for CTRI (annual period ending 2025-12-31)
ROE: 3.148864115044063%
Net margin: 0.7593584644665499%
Asset turnover: 1.3309759541071855
Equity multiplier (leverage): 3.1155653983625906
EBIT margin: 3.1118945708719483%
Interest burden factor: 0.1571519376003275
Tax burden factor: 1.5527524508123671
ROE archetype: Low Return
DuPont ROE decomposition for CTRM (annual period ending 2022-12-31)
ROE: 25.690565355130772%
Net margin: 78.92673709541045%
Asset turnover: 0.23725257722685847
Equity multiplier (leverage): 1.371950915357577
EBIT margin: 48.6590388129424%
Interest burden factor: 0.9156681233580584
Tax burden factor: 1.7714240131204142
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CTRM (annual period ending 2023-12-31)
ROE: 8.113169637752515%
Net margin: 39.62701687529485%
Asset turnover: 0.1610165819690674
Equity multiplier (leverage): 1.2715357454568141
EBIT margin: 16.022123906011217%
Interest burden factor: 1.374863863775194
Tax burden factor: 1.798918949115379
ROE archetype: Standard Business
DuPont ROE decomposition for CTRM (annual period ending 2024-12-31)
ROE: 5.7773234903394854%
Net margin: 51.03060035630127%
Asset turnover: 0.09182900427833818
Equity multiplier (leverage): 1.2328667298094353
EBIT margin: 12.848831277160544%
Interest burden factor: 1.8138896786700347
Tax burden factor: 2.189556628370815
ROE archetype: Standard Business
DuPont ROE decomposition for CTRM (annual period ending 2025-12-31)
ROE: 3.523544544609785%
Net margin: 26.330525779659464%
Asset turnover: 0.10884139694618086
Equity multiplier (leverage): 1.2294931902066968
EBIT margin: -0.11352890728717026%
Tax burden factor: 0.961358989490911
ROE archetype: Low Return
DuPont ROE decomposition for CTV.V (quarterly period ending 2024-12-31)
ROE: -8.556971284156315%
Asset turnover: 0
Equity multiplier (leverage): 1.4363744684251092
ROE archetype: Low Return
DuPont ROE decomposition for CTV.V (quarterly period ending 2025-03-31)
ROE: -5.5033277241969945%
Asset turnover: 0
Equity multiplier (leverage): 1.4149379651732021
ROE archetype: Low Return
DuPont ROE decomposition for CTV.V (quarterly period ending 2025-06-30)
ROE: -8.92060467786563%
Asset turnover: 0
Equity multiplier (leverage): 1.395069698598667
ROE archetype: Low Return
DuPont ROE decomposition for CTV.V (quarterly period ending 2025-09-30)
ROE: -17.047525797476226%
Asset turnover: 0
Equity multiplier (leverage): 1.396533547341706
ROE archetype: Low Return
DuPont ROE decomposition for CTV.V (quarterly period ending 2025-12-31)
ROE: -1.9452252766380942%
Asset turnover: 0
Equity multiplier (leverage): 1.3910188994095263
ROE archetype: Low Return
DuPont ROE decomposition for CTV.V (quarterly period ending 2026-03-31)
ROE: 1.474733191510438%
Asset turnover: 0
Equity multiplier (leverage): 1.3794997512200442
Interest burden factor: 1.021180115653341
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CTXR (quarterly period ending 2025-03-31)
ROE: -17.170851760682744%
Asset turnover: 0
Equity multiplier (leverage): 1.9108123890930058
ROE archetype: Low Return
DuPont ROE decomposition for CTXR (quarterly period ending 2025-06-30)
ROE: -13.405660696627752%
Asset turnover: 0
Equity multiplier (leverage): 1.899988547830256
ROE archetype: Low Return
DuPont ROE decomposition for CTXR (quarterly period ending 2025-09-30)
ROE: -10.971629528536818%
Asset turnover: 0
Equity multiplier (leverage): 1.782462638500783
ROE archetype: Low Return
DuPont ROE decomposition for CTXR (quarterly period ending 2025-12-31)
ROE: -9.615202311966328%
Net margin: -208.4318874392734%
Asset turnover: 0.029072454659460404
Equity multiplier (leverage): 1.586764820866412
EBIT margin: -228.67530858031125%
ROE archetype: Low Return
DuPont ROE decomposition for CTXR (quarterly period ending 2026-03-31)
ROE: -26.12219067187287%
Net margin: -1273.38604136753%
Asset turnover: 0.012217666762200733
Equity multiplier (leverage): 1.679040743034176
EBIT margin: -1930.9557139755461%
ROE archetype: Low Return
DuPont ROE decomposition for CURB (quarterly period ending 2025-03-31)
ROE: 0.545710063757453%
Net margin: 27.295516216565446%
Asset turnover: 0.018246471421484767
Equity multiplier (leverage): 1.0957002469697126
EBIT margin: 13.130895464530301%
Interest burden factor: 2.0993898838811256
Tax burden factor: 0.9901565576075748
ROE archetype: Low Return
DuPont ROE decomposition for CURB (quarterly period ending 2025-06-30)
ROE: 0.53855137133676%
Net margin: 25.134051495096855%
Asset turnover: 0.019462746037301325
Equity multiplier (leverage): 1.1009320623603776
EBIT margin: 15.868798608762862%
Interest burden factor: 1.5948249619482495
Tax burden factor: 0.9931284596297003
ROE archetype: Low Return
DuPont ROE decomposition for CURB (quarterly period ending 2025-09-30)
ROE: 0.485814406229721%
Net margin: 19.236540793882458%
Asset turnover: 0.021247439176273555
Equity multiplier (leverage): 1.188602985074627
EBIT margin: 18.428680083047258%
Interest burden factor: 1.048745119910764
Tax burden factor: 0.9953201446500745
ROE archetype: Low Return
DuPont ROE decomposition for CURB (quarterly period ending 2025-12-31)
ROE: 0.4980467757400399%
Net margin: 17.64575523093686%
Asset turnover: 0.022033822440326506
Equity multiplier (leverage): 1.2809731797511017
EBIT margin: 18.47125524017064%
Interest burden factor: 0.9639072185562887
Tax burden factor: 0.9910797635100094
ROE archetype: Low Return
DuPont ROE decomposition for CURB (quarterly period ending 2026-03-31)
ROE: 0.187162135757069%
Net margin: 6.1531032817700515%
Asset turnover: 0.02278069704525084
Equity multiplier (leverage): 1.3352321442575241
EBIT margin: 13.14260092779416%
Interest burden factor: 0.477233958798058
Tax burden factor: 0.9810283200439923
ROE archetype: Low Return
DuPont ROE decomposition for CURY.L (annual period ending 2022-04-30)
ROE: 2.838864454218313%
Net margin: 0.6999211356466877%
Asset turnover: 1.4673802979892956
Equity multiplier (leverage): 2.764094362255098
EBIT margin: 2.1884858044164037%
Interest burden factor: 0.5675675675675675
Tax burden factor: 0.5634920634920635
ROE archetype: Low Return
DuPont ROE decomposition for CURY.L (annual period ending 2023-04-30)
ROE: -21.89847484634646%
Net margin: -5.420329051160694%
Asset turnover: 1.3906911142454161
Equity multiplier (leverage): 2.905076257682677
EBIT margin: 1.656524678837052%
Interest burden factor: -3.142857142857143
ROE archetype: Low Return
DuPont ROE decomposition for CURY.L (annual period ending 2024-04-30)
ROE: 8.324924318869828%
Net margin: 1.9466729589428977%
Asset turnover: 1.5192686861444704
Equity multiplier (leverage): 2.8148335015136228
EBIT margin: 1.3803680981595092%
Interest burden factor: 0.23931623931623933
Tax burden factor: 5.892857142857143
ROE archetype: Standard Business
DuPont ROE decomposition for CURY.L (annual period ending 2025-04-30)
ROE: 5.160673754629077%
Net margin: 1.2405237767057202%
Asset turnover: 1.6742005853259856
Equity multiplier (leverage): 2.4848136423366385
EBIT margin: 2.2742935906271535%
Interest burden factor: 0.6262626262626263
Tax burden factor: 0.8709677419354838
ROE archetype: Standard Business
DuPont ROE decomposition for CUV.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.1284895251219116
ROE archetype: Standard Business
DuPont ROE decomposition for CVKD (annual period ending 2023-12-31)
ROE: -780.5892421394295%
Asset turnover: 0
Equity multiplier (leverage): 4.3421051033870794
ROE archetype: Low Return
DuPont ROE decomposition for CVKD (annual period ending 2024-12-31)
ROE: -140.77984661593516%
Asset turnover: 0
Equity multiplier (leverage): 1.2320145784251204
ROE archetype: Low Return
DuPont ROE decomposition for CVKD (annual period ending 2025-12-31)
ROE: -260.1094622766609%
Asset turnover: 0
Equity multiplier (leverage): 1.419710519466854
ROE archetype: Low Return
DuPont ROE decomposition for CVLG (quarterly period ending 2025-03-31)
ROE: 1.4793392900614006%
Net margin: 2.4365614152326853%
Asset turnover: 0.2748607353906093
Equity multiplier (leverage): 2.2089084941980506
EBIT margin: 2.952609010413766%
Interest burden factor: 1.0745630579655476
Tax burden factor: 0.7679616194710975
ROE archetype: Low Return
DuPont ROE decomposition for CVLG (quarterly period ending 2025-06-30)
ROE: 2.2869945776846037%
Net margin: 3.2490903207486115%
Asset turnover: 0.3045195697869497
Equity multiplier (leverage): 2.3114693707743474
EBIT margin: 3.9154179901866906%
Interest burden factor: 1.1267498735031203
Tax burden factor: 0.7364718209714842
ROE archetype: Low Return
DuPont ROE decomposition for CVLG (quarterly period ending 2025-09-30)
ROE: 2.1634804125673637%
Net margin: 3.062760829805079%
Asset turnover: 0.29188435091914045
Equity multiplier (leverage): 2.4200763749271346
EBIT margin: 2.50565025986143%
Interest burden factor: 1.0802527221400726
Tax burden factor: 1.1315331010452963
ROE archetype: Low Return
DuPont ROE decomposition for CVLG (quarterly period ending 2025-12-31)
ROE: -4.411437794788525%
Net margin: -6.180977337206389%
Asset turnover: 0.2852824196860265
Equity multiplier (leverage): 2.501773563751643
EBIT margin: -2.2964106522578156%
ROE archetype: Low Return
DuPont ROE decomposition for CVLG (quarterly period ending 2026-03-31)
ROE: 1.0892051636210405%
Net margin: 1.4389847669463247%
Asset turnover: 0.29787099927462307
Equity multiplier (leverage): 2.5411205752580392
EBIT margin: 2.155221528774812%
Interest burden factor: 0.9188821752265861
Tax burden factor: 0.7266151569949039
ROE archetype: Low Return
DuPont ROE decomposition for CVW.V (quarterly period ending 2025-03-31)
ROE: -4.334195348496729%
Asset turnover: 0
Equity multiplier (leverage): 1.019091187940109
ROE archetype: Low Return
DuPont ROE decomposition for CVW.V (quarterly period ending 2025-06-30)
ROE: -6.669927468626574%
Asset turnover: 0
Equity multiplier (leverage): 1.0191844359221731
ROE archetype: Low Return
DuPont ROE decomposition for CVW.V (quarterly period ending 2025-09-30)
ROE: -5.522387718697237%
Net margin: -276.7594800296356%
Asset turnover: 0.01951730862523111
Equity multiplier (leverage): 1.0223614350980346
EBIT margin: -282.66424193439747%
ROE archetype: Low Return
DuPont ROE decomposition for CVW.V (quarterly period ending 2025-12-31)
ROE: 10.344539267148777%
Asset turnover: -0.05664264328927863
Equity multiplier (leverage): 1.028328326424373
Interest burden factor: 4.582195858315261
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CVW.V (quarterly period ending 2026-03-31)
ROE: -1.1914344512136237%
Asset turnover: 0
Equity multiplier (leverage): 1.0164250445502234
ROE archetype: Low Return
DuPont ROE decomposition for CWD (quarterly period ending 2025-03-31)
ROE: -59.60858929056809%
Net margin: -60.40490290593582%
Asset turnover: 0.07005779454473529
Equity multiplier (leverage): 14.08575699918456
EBIT margin: -35.931689849882936%
ROE archetype: Low Return
DuPont ROE decomposition for CWD (quarterly period ending 2025-06-30)
Net margin: -104.45495761876602%
Asset turnover: 0.0622824625697501
EBIT margin: -36.03390498718707%
ROE archetype: Standard Business
DuPont ROE decomposition for CWD (quarterly period ending 2025-09-30)
Net margin: -118.53685368536853%
Asset turnover: 0.0512733733818428
EBIT margin: -51.26512651265126%
ROE archetype: Standard Business
DuPont ROE decomposition for CWD (quarterly period ending 2025-12-31)
ROE: -47.781422117705304%
Net margin: -187.08504967288587%
Asset turnover: 0.03786863885779303
Equity multiplier (leverage): 6.744352992140603
EBIT margin: -30.845650593651563%
ROE archetype: Low Return
DuPont ROE decomposition for CWD (quarterly period ending 2026-03-31)
ROE: -11.144643242078034%
Net margin: -84.28039124359572%
Asset turnover: 0.027264357598653925
Equity multiplier (leverage): 4.850029255073446
EBIT margin: -63.92640894271076%
ROE archetype: Low Return
DuPont ROE decomposition for CWEN (quarterly period ending 2025-03-31)
ROE: -0.05536076766931168%
Net margin: -1.006711409395973%
Asset turnover: 0.020345463234792107
Equity multiplier (leverage): 2.7028972135080274
EBIT margin: 1.006711409395973%
Interest burden factor: -34.666666666666664
ROE archetype: Low Return
DuPont ROE decomposition for CWEN (quarterly period ending 2025-06-30)
ROE: 0.600054550413674%
Net margin: 8.418367346938775%
Asset turnover: 0.025554106910039114
Equity multiplier (leverage): 2.789344485862351
EBIT margin: 22.193877551020407%
Interest burden factor: 0.19540229885057472
Tax burden factor: 1.9411764705882353
ROE archetype: Low Return
DuPont ROE decomposition for CWEN (quarterly period ending 2025-09-30)
ROE: 4.1516404257190604%
Net margin: 55.011655011655016%
Asset turnover: 0.02672980466681205
Equity multiplier (leverage): 2.8233793649397483
EBIT margin: 26.806526806526808%
Interest burden factor: 0.25217391304347825
Tax burden factor: 8.137931034482758
ROE archetype: Low Return
DuPont ROE decomposition for CWEN (quarterly period ending 2025-12-31)
ROE: -1.7773220541741432%
Net margin: -33.5483870967742%
Asset turnover: 0.018948076159041594
Equity multiplier (leverage): 2.7959497564726994
EBIT margin: -9.35483870967742%
ROE archetype: Low Return
DuPont ROE decomposition for CWEN (quarterly period ending 2026-03-31)
ROE: -1.1844626371712246%
Net margin: -19.2090395480226%
Asset turnover: 0.02108021199309236
Equity multiplier (leverage): 2.9251001567671135
EBIT margin: 7.627118644067797%
Interest burden factor: -2.5925925925925926
ROE archetype: Low Return
DuPont ROE decomposition for CWK.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.5069148936170211
ROE archetype: Standard Business
DuPont ROE decomposition for CWK.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.5286862721671304
ROE archetype: Standard Business
DuPont ROE decomposition for CWK.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.6158461654912313
ROE archetype: Standard Business
DuPont ROE decomposition for CWK.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.6354951830978446
ROE archetype: Standard Business
DuPont ROE decomposition for CWR.L (annual period ending 2022-12-31)
ROE: -20.36857212523581%
Net margin: -240.62563169597735%
Asset turnover: 0.07625227835857992
Equity multiplier (leverage): 1.1101096390850718
EBIT margin: -272.9583586011724%
ROE archetype: Low Return
DuPont ROE decomposition for CWR.L (annual period ending 2023-12-31)
ROE: -26.793927537644763%
Net margin: -241.92796989786777%
Asset turnover: 0.0984796968391835
Equity multiplier (leverage): 1.1246142816779456
EBIT margin: -266.0858269127396%
ROE archetype: Low Return
DuPont ROE decomposition for CWR.L (annual period ending 2024-12-31)
ROE: -16.810464836591517%
Net margin: -54.547031277100075%
Asset turnover: 0.26604813586520404
Equity multiplier (leverage): 1.1583728853008541
EBIT margin: -60.351506041510085%
ROE archetype: Low Return
DuPont ROE decomposition for CWR.L (annual period ending 2025-12-31)
ROE: -38.04569888897012%
Net margin: -145.65450479428975%
Asset turnover: 0.20837091849122744
Equity multiplier (leverage): 1.2535583072880745
EBIT margin: -135.40728486965048%
ROE archetype: Low Return
DuPont ROE decomposition for CXO.AX (annual period ending 2022-06-30)
ROE: -3.1273145510192273%
Equity multiplier (leverage): 1.09688337516568
ROE archetype: Low Return
DuPont ROE decomposition for CXO.AX (annual period ending 2023-06-30)
ROE: 3.582287271878024%
Net margin: 21.364480809518163%
Asset turnover: 0.13043553572240646
Equity multiplier (leverage): 1.2855001761441414
EBIT margin: 20.340724929839123%
Interest burden factor: 0.8966187329965021
Tax burden factor: 1.171434763762462
ROE archetype: Low Return
DuPont ROE decomposition for CXO.AX (annual period ending 2024-06-30)
ROE: -67.93508902030396%
Net margin: -109.24514760361805%
Asset turnover: 0.46006590866460756
Equity multiplier (leverage): 1.3516739383095022
EBIT margin: -37.43495836279777%
ROE archetype: Low Return
DuPont ROE decomposition for CXO.AX (annual period ending 2025-06-30)
ROE: -9.417910278143895%
Asset turnover: -0.008085198016217685
Equity multiplier (leverage): 1.2067018123573459
ROE archetype: Low Return
DuPont ROE decomposition for CXSE3.SA (annual period ending 2022-12-31)
ROE: 24.408799281598583%
Net margin: 178.31515294460664%
Asset turnover: 0.12834665624544117
Equity multiplier (leverage): 1.0665313039196518
Tax burden factor: 0.8658308279850093
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CXSE3.SA (annual period ending 2023-12-31)
ROE: 29.965256482700052%
Net margin: 179.6171036784401%
Asset turnover: 0.15293653941762378
Equity multiplier (leverage): 1.0908349678757663
Tax burden factor: 0.8812200253081354
ROE archetype: High-Margin Compounder